WFG Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $271K | Buy |
5,032
+718
| +17% | +$38.7K | 0.06% | 299 |
|
|
2017
Q1 | $227K | Buy |
4,314
+304
| +8% | +$16K | 0.06% | 306 |
|
|
2016
Q4 | $193K | Buy |
4,010
+315
| +9% | +$15.2K | 0.05% | 395 |
|
|
2016
Q3 | $199K | Buy |
3,695
+618
| +20% | +$33.3K | 0.05% | 377 |
|
|
2016
Q2 | $167K | Buy |
3,077
+994
| +48% | +$53.9K | 0.04% | 384 |
|
|
2016
Q1 | $106K | Sell |
2,083
-195
| -9% | -$9.92K | 0.03% | 460 |
|
|
2015
Q4 | $115K | Sell |
2,278
-303
| -12% | -$15.3K | 0.03% | 431 |
|
|
2015
Q3 | $124K | Buy |
2,581
+9
| +0.3% | +$432 | 0.04% | 407 |
|
|
2015
Q2 | $134K | Buy |
2,572
+574
| +29% | +$29.9K | 0.04% | 457 |
|
|
2015
Q1 | $115K | Sell |
1,998
-1,279
| -39% | -$73.6K | 0.03% | 490 |
|
|
2014
Q4 | $175K | Sell |
3,277
-868
| -21% | -$46.4K | 0.04% | 471 |
|
|
2014
Q3 | $238K | Buy |
4,145
+66
| +2% | +$3.79K | 0.05% | 406 |
|
|
2014
Q2 | $273K | Buy |
4,079
+641
| +19% | +$42.9K | 0.05% | 379 |
|
|
2014
Q1 | $230K | Sell |
3,438
-555
| -14% | -$37.1K | 0.05% | 402 |
|
|
2013
Q4 | $266K | Sell |
3,993
-56
| -1% | -$3.73K | 0.04% | 445 |
|
|
2013
Q3 | $254K | Sell |
4,049
-243
| -6% | -$15.2K | 0.04% | 424 |
|
|
2013
Q2 | $268K | Buy |
+4,292
| New | +$268K | 0.04% | 395 |
|